Characterization of bacterial isolates from diabetic foot infections in Ile-Ife, Southwestern Nigeria

Foot

Volumn 16, Issue 3, 2006, Pages 158-164

  Ako Nai, A K ^a   Ikem, I C ^a   Akinloye, O O ^a   Aboderin, A O ^a   Ikem, R T ^b   Kassim, O O ^c  

^a OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^b Faculty of Clinical Sciences   (Nigeria)

^c HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Bacterial aetiology; Diabetes; Foot infections; Multi resistance

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CLOXACILLIN; COTRIMOXAZOLE; DEOXYRIBONUCLEASE; ERYTHROMYCIN; GENTAMICIN; NALIDIXIC ACID; NITROFURANTOIN; OFLOXACIN; PROTEINASE; RIBONUCLEASE; TETRACYCLINE; THIOGLYCOLIC ACID; TRIACYLGLYCEROL LIPASE;

ADULT; AEROBIC BACTERIUM; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BIOPSY TECHNIQUE; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; CORYNEBACTERIUM; CULTURE MEDIUM; DIABETIC FOOT; ENZYME ASSAY; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN TISSUE; INOCULATION; MALE; NIGERIA; NONHUMAN; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEUS; PSEUDOMONAS AERUGINOSA; STANDARDIZATION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; VOLUNTEER;

EID: 33746280306     PISSN: 09582592     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foot.2006.05.001     Document Type: Article

References (33)

1. Shea K.W. Antimicrobial therapy for diabetic foot infections. A practical approach. Postgrad Med 106 1 (1999) 89-94 85-86
2. Akanji A.O., and Adetunyibi A. The pattern of foot lesions in Nigerian diabetic patients West African l. J Med 9 (1991) 1-5
3. Calhoun J.H., Cantrell J., Cobos J., Lacy J., Valdez R.R., Hoksanson J., et al. Treatment of diabetic foot infections: Wagner classification, therapy and outcome. Foot Ankle 9 (1988) 101-106
4. Shea J.D. Pressure Sores: classification and management. Clin Orthop Relat Res 112 (1975) 89-100
5. Ikem R.T., Kolawole B.A., and Ikem I.C. The prevalence, presentation and outcome of diabetic foot lesions in a Nigerian teaching hospital. Trop Doct 32 (2002) 226-227
6. Shaw J.E., and Boulton A.J.M. The pathogenesis of diabetic foot problems: an overview. Diabetes 46 Suppl. 2 (1997) S58-S61
7. Moss S.E., Klein R., and Klein B.E. Long term incidence of lower-extremity amputations in a diabetic population. Kidney Int 56 (1999) 1524-1533
8. Reike H. Schwerpunkt Fubklink-Qualitatsstandards verhindern Amputationen. SchulungsProft Diab 3 (1997) 14-20
9. Wagner W.F. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 2 (1981) 64-67
10. Hankin L., and Anagnostakis S. The use of solid media for detection of enzyme production by fungi. Mycologia 67 (1975) 597-607
11. Jeffries C.D., Holtoman F., and Guge D.G. Rapid method for determining the activity of micro-organisms on nuclei acids. J Bacteriol 73 (1957) 590-591
12. Bauer A.W., Kirby W.W.M., Sherris J.C., and Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45 (1966) 493-495
13. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed. (1997), National Committee for Clinical Laboratory Standards, Wayne, PA
14. Kelkar U., and Kagal A. Bacteriology of diabetic ulcers: effect of sample collection method. Diab Foot Autumn (2004)
15. Lipsky B.A., Pecoraro R.E., Larson S.A., et al. Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Arch Intern Med 150 4 (1990) 790-797
16. Anandi C., Alaguraja D., Natarajan V., Ramanathan M., Subramaniam C.S., Thulasiram M., et al. Bacteriology of diabetic foot lesions. Ind J Med Microbiol 3 (2004) 175-178
17. Pathare N.A., Bal A., Talvalkar G.V., and Antai D.V. Diabetic foot infections a study of microorganisms associated with the different Wagner grades. Ind J Pathol Microbiol 41 4 (1998) 437-441
18. Wheat L.J., Allen S.D., Henry M., Kerneck C.B., Siders J.A., Kuebler T., et al. Diabetic foot infections. Bacteriologic analysis. Arch Intern Med 146 (1986) 1935-1940
19. Sims D., Keating S.E., and DeVincentis A.F. Bacteriology of diabetic foot ulcers. J Foot Surg 23 (1984) 149-151
20. Louie T.J., Bartlett J.G., Tally F.P., et al. Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann Intern Med 85 (1976) 461-463
21. Gokel Y., Murat S., Tetiker T., Kokak M., and Bozdemir H. Effective factors in diabetic foot development and prognosis. Ann Med Sci 9 (2000) 120-124
22. Smith JMB, Payne JE, Berue TV. Diabetic foot lesions of skin and soft tissue infections of surgical importance. The surgeons guide to antimicrobial chemotherapy 2002; 218-221.
23. Meade J.W., and Muller C.B. Major infections of the foot. Med Times 96 (1968) 154-165
24. Bailey T.S., Yu H.M., and Rayfield E.J. Patterns of foot examination in a diabetic clinic. Am J Med 78 (1985) 371-374
25. Ge Y., macDonald D., Halt H., Lipsky B., Zasloff M., and holroyd K. Microbiological profile of infected diabetic foot ulcers. Diab Med 19 (2002) 1032-1035
26. Jones E.W., Edwards R., Finch R., et al. A microbiological study of diabetic lesions. Diab Med 2 (1985) 213-215
27. Bowler P.G., and Davies B.J. The microbiology of infected and non-infected leg ulcers. Int J Dermatol 38 (1999) 101-106
28. Sapico F.L., Witte J.L., Canawati H.N., Montgomerie J.Z., and Bessman A.N. The infected foot of the diabetic patient: quantitative microbiology and analysis of clinical features. Rev Infect Dis 6 (1984) S171-S176
29. Ako-nai A.K., Ogunniyi A.D., Lamikanra A., and Torimiro S.E.A. The characterization of clinical isolates of Staphylococcus aureus in ILe-Ife, Nigeria. J Med Microbiol 34 2 (1991) 109-112
30. MacFaddin J.F. Biochemical tests for the identification of medical bacteria. 2nd ed. (1980), Williams and Wilkins, Baltimore pp. 64-76
31. Berman R.E., Gilpin R.W., and Knight R.A. Exotoxin synthesis by clinical isolates of staphylococci. Lab Med 12 (1981) 621-654
32. Boyd R.F., and Hoerl B.G. Basic medical microbiology. 2nd ed. (1981), Little Brown and Company, Boston p. 766
33. Tan J.S., Wishnow R.M., Talan D.A., Duncanson F.P., and Norden C.W. Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. The Piperacillin/Tazobactam Skin and Skin Structure Study Group. Antimicrob Agents Chemother 37 8 (1993) 1580-1586